skip to content


Issue No. 33 | July 31, 2009

News and Features

Study: Immune Systems of Untreated HIV-Infected Individuals May Deteriorate More Quickly than Thought

"The immune systems of untreated HIV-infected individuals appear to deteriorate faster than previously thought, according to preliminary results of a small clinical trial. This finding suggests that clinicians may need to monitor people with recent HIV infection as closely as they monitor people with more advanced disease, the study investigators postulate."

Study: Chronic Alcohol Consumption Affects Short-Term Memory in HIV-Infected Individuals

"The study ... found that more than half of clinic patients with the virus that causes AIDS are also heavy drinkers and they appear to have more problems with short-term episodic memory, while long-term working memory seems unaffected."

  • Read the full story

Study: Abacavir/Lamivudine and Tenofovir DF/Emtricitabine Show Comparable Efficacy when Combined with Kaletra

"Abacavir sulfate/lamivudine (ABC/3TC) and tenofovir DF/emtricitabine (TDF/FTC) are widely used nucleoside reverse transcriptase inhibitors for initial HIV-1 treatment. This is the first completed, randomized clinical trial to directly compare the efficacy, safety, and tolerability of these agents, each in combination with lopinavir/ritonavir in antiretroviral-naive patients.

"Both ABC/3TC and TDF/FTC provided comparable antiviral efficacy, safety, and tolerability when each was combined with lopinavir/ritonavir in treatment-naive patients."

  • Read the study abstract

At-a-Glance Hiatus

AIDSinfo At-a-Glance is going on hiatus for the next few weeks but will be back soon with more weekly HIV/AIDS treatment updates.

Thank you for subscribing to AIDSinfo At-a-Glance!